Objective:
Adapt Siloton’s compact Akepa optical coherence tomography (OCT) system for pediatric use, with the aim of making monitoring of sight-threatening disease more accessible.
Approach:
- Partnership and funding: UCL Great Ormond Street Institute of Child Health researchers are partnering with Siloton on an NIHR-funded project.
- Device adaptation: The team plans to adjust the optics to focus within children’s eyes and reshape the casing to fit younger faces and limit ambient-light interference.
- Potential settings and conditions: The project will explore imaging in community settings and potentially patients’ homes, across conditions including inherited retinal disease, diabetes-related changes, and optic-disc abnormalities.
Key Findings:
- Akepa integrates around 70% of its OCT system onto a chip smaller than a British £1 coin and includes more than 300 optical and electronic elements.
- The platform was designed for a binocular-style device and was trialled in an initial adult cohort in 2025.
- The project team says home or community imaging could reduce repeated hospital visits and support closer monitoring.
Interpretation:
The project is adapting a compact OCT platform for children; its use in pediatric settings is being explored.
Limitations:
- The provided source describes planned adaptations and applications, but does not report pediatric trial results.
- The initial Akepa trial described was in adults.
Conclusion:
The project is funded by the National Institute for Health and Care Research and involves UCL researchers Ameenat Lola Solebo and Marinko Sarunic and Siloton.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.